Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: A comparative study

European Journal of Medicinal Chemistry

Volumn 39, Issue 3, 2004, Pages 219-224

  Daidone, Giuseppe ^a   Raffa, Demetrio ^a   Maggio, Benedetta ^a   Raimondi, Maria Valeria ^a   Plescia, Fabiana ^a   Schillaci, Domenico ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Antiproliferative activity; Hindered rotation; Triazenoindazoles; Triazenopyrazoles

Indexed keywords

BENZENE DERIVATIVE; DIAZONIUM COMPOUND; DIETHYLAMINE; DIMETHYLAMINE; INDAZOLE DERIVATIVE; NITROGEN DERIVATIVE; PYRAZOLE DERIVATIVE; PYRROLE DERIVATIVE; TRIAZENE DERIVATIVE;

ARTICLE; BIOLOGY; CELL LINE; CELL STRAIN HL 60; CELL STRAIN K 562; CELL STRAIN MCF 7; CHEMICAL BOND; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; EXPERIMENTAL TEST; HUMAN; HUMAN CELL; LEUKEMIA L 1210; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; ROTATION; SPECTRUM; SUBSTITUTION REACTION;

ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDAZOLES; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZENES; TUMOR CELLS, CULTURED;

EID: 1642346523     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmech.2003.11.012     Document Type: Article

References (25)

1. Fulmer Shealy Y. Triazenylimidazoles, other triazenes, and imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)ones. Foye W.O. Cancer Chemotherapic Agents. 1995;173-174 ACS, Washington.
2. Carvalho E., Francisco A.P., Iley J., Rosa E. Bioorg. Med. Chem. 8:2000;1719-1725.
3. Gadjeva V., Vesselina G. Int. J. Pharm. 247:2002;39-45.
4. Diana P., Barraja P., Lauria A., Almerico A.M., Cirrincione G., Loi A., Musiu C., Pani A., La Colla P., Marongiu M. Eur. J. Med. Chem. 34:1999;353-360.
5. Skiba J.L., Bryan G.T. Toxicol. Appl. Pharmacol. 18:1971;707-719.
6. Mizuno N.S., Humphrey E.W. Cancer Chemoth. Rep. Part 1. 56:1972;465-472.
7. Catapano C.V., Broggini M., Erba E., Ponti M., Mariani L., Citti L., D'Incalci M. Cancer Res. 47:1987;4884-4889.
8. Van Delft J.H.M., Luiten-Schuite A., Souliotis V.L., Kyrtopoulos S.A., Ouwerkerk J., Keizer H.J., Baan R.A. Biomarkers. 1:1996;94-98.
9. V.S. Lucas, A.T. Huang, Chemotherapy of melanoma, in: H.F. Siegler (Ed.), Development in Oncology, Martinus Nijhoff, The Hague, The Netherlands, vol. 5, p. 382.
10. Housholder G.E., Loo T.L. Life Sci. 8:1969;533-536.
11. Housholder G.E., Loo T.L. J. Pharmacol. Exp. Ther. 179:1971;386-395.
12. Vaughan K. Triazenes. Wilman D.E.V. Chemistry of Antitumor Agents. 1990;159-164 Chapman and Hall, NY.
13. Gerulatth A.H., Loo T.L. Biochem. Pharmacol. 21:1972;2335-2343.
14. Saunders P.P., Chao L.Y. Cancer Res. 34:1974;2464-2469.
15. Fulmer Shealy Y. Triazenylimidazoles, other triazenes, and imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)ones. Foye W.O. Cancer Chemotherapic Agents. 1995;172-173 ACS, Washington.
16. Cirrincione G., Almerico A.M., Dattolo G., Aiello E., Diana P., Grimaudo S., Mingoia S., Barraja P., Gancitano R.A. Eur. J. Med. Chem. 29:1994;889-891.
17. Diana P., Barraja P., Lauria A., Almerico A.M., Cirrincione G., Minnei C., Longu C., Congiu D., Musiu C., La Colla P. Anticancer Res. 19:1999;2127-2131.
18. Clark A.S., Deans B., Stevens M.G., Tisdale M.J., Wheelhouse R.T., Denny B.J., Hartley J.A. J. Med. Chem. 38:1995;1493-1504.
19. Shealy Y.F., O'Dell C.A. J. Pharm. Sci. 60:1971;554-560.
20. Hisamitzu Pharmaceutical Co, Inc, Jpn Kokai Tokkio 88,147,279; (Chem Abstr 94, 121596y, 1994).
21. Lafferty J.J., Tedeschi D.H., Zirkle C.L. Reissue US. 28:24 Aug 1976;939. (Chem Abstr 86, 29826k).
22. Still W.C., Khan M., Mitra A. J. Org. Chem. 43:1978;2923-2925.
23. Alcade E., De Mendoza J., Garcia-Marquina J.M., Almera C., Elguero J. J. Heterocyclic Chem. 11:1974;423-429.
24. Kocevar M., Colman D., Krajnc H., Polanc S., Porovne B., Stanovnik B., Tisler M. Tetrahedron. 32:1976;725-729.
25. Shusterman A.J., Kumar Debnath A., Hansch C., Horn G.W., Fronczek F.A., Green A.C., Watkins S.F. Mol. Pharmacol. 36:1989;939-944.